| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |